We are live on ! Find out more
HRTX icon

Heron Therapeutics
HRTX

198 hedge funds and large institutions have $2.27B invested in Heron Therapeutics in 2019 Q1 according to their latest regulatory filings, with 35 funds opening new positions, 77 increasing their positions, 51 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

450% more call options, than puts

Call options by funds: $45.1M | Put options by funds: $8.19M

192% more first-time investments, than exits

New positions opened: 35 | Existing positions closed: 12

51% more repeat investments, than reductions

Existing positions increased: 77 | Existing positions reduced: 51

22% more funds holding in top 10

Funds holding in top 10: 9 → 11 (+2)

13% more funds holding

Funds holding: 176 → 198 (+22)

1.49% more ownership

Funds ownership: 117.09% → 118.58% (+1.5%)

4% less capital invested

Capital invested by funds: $2.37B → $2.27B (-$103M)

Holders
198
Holders Change
+22
Holders Change %
+12.5%
% of All Funds
4.29%
Holding in Top 10
11
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+22.22%
% of All Funds
0.24%
New
35
Increased
77
Reduced
51
Closed
12
Calls
$45.1M
Puts
$8.19M
Net Calls
+$36.9M
Net Calls Change
+$33.5M

Top Buyers

Rank Fund Capital Flow
1
ClearBridge Investments
ClearBridge Investments
New York
+$34.6M
2
JP Morgan Chase
JP Morgan Chase
New York
+$17.7M
3
Wellington Management Group
Wellington Management Group
Massachusetts
+$14.8M
4
WM
WS Management
Florida
+$12M
5
ACH
ArrowMark Colorado Holdings
Colorado
+$11.6M

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$44.3M
2
RCMNY
Rubric Capital Management (New York)
New York
-$33.7M
3
CC
Carlson Capital
Texas
-$12.7M
4
Fidelity International
Fidelity International
Bermuda
-$12.6M
5
BM
Bridger Management
New York
-$11.7M
Name Holding Trade Value Shares
Change 		Change in
Stake
EU
76
Emory University
Georgia
$2.11M +$57.9K +2,212 +3%
Squarepoint
77
Squarepoint
New York
$1.89M -$738K -28,179 -27%
First Trust Advisors
78
First Trust Advisors
Illinois
$1.84M +$113K +4,335 +6%
PNC Financial Services Group
79
PNC Financial Services Group
Pennsylvania
$1.8M +$703K +26,867 +57%
TI
80
Trexquant Investment
Connecticut
$1.73M +$1.85M +70,639 New
RA
81
Royce & Associates
New York
$1.71M – – –
California Public Employees Retirement System
82
California Public Employees Retirement System
California
$1.69M -$29.3K -1,119 -2%
USAA
83
United Services Automobile Association
Texas
$1.67M +$183K +7,000 +11%
ACM
84
Asymmetry Capital Management
California
$1.66M +$970K +37,048 +120%
Fisher Asset Management
85
Fisher Asset Management
Washington
$1.64M – – –
Millennium Management
86
Millennium Management
New York
$1.58M +$1.69M +64,650 New
Morgan Stanley
87
Morgan Stanley
New York
$1.57M -$9.57M -365,531 -85%
FI
88
Fosun International
China
$1.54M – – –
OAM
89
Oxford Asset Management
United Kingdom
$1.51M +$1.62M +61,998 New
DekaBank Deutsche Girozentrale
90
DekaBank Deutsche Girozentrale
Germany
$1.5M +$1.02M +39,000 New
UBS AM
91
UBS AM
Illinois
$1.41M +$250K +9,551 +20%
UBS Group
92
UBS Group
Switzerland
$1.39M -$3.89M -148,476 -72%
Stifel Financial
93
Stifel Financial
Missouri
$1.37M +$1.49M +56,803 New
CS
94
Credit Suisse
Switzerland
$1.35M -$1.01M -38,470 -41%
Envestnet Asset Management
95
Envestnet Asset Management
Illinois
$1.25M +$158K +6,047 +13%
CPC
96
Congress Park Capital
New York
$1.24M +$113K +4,300 +9%
T. Rowe Price Associates
97
T. Rowe Price Associates
Maryland
$1.15M +$10K +383 +0.8%
RAM
98
Redmond Asset Management
Virginia
$1.1M +$1.18M +45,131 New
Russell Investments Group
99
Russell Investments Group
United Kingdom
$1.1M +$87.4K +3,337 +8%
Man Group
100
Man Group
United Kingdom
$1.08M -$438K -16,742 -28%
2 3
4
5 6

HRTX Hedge Fund Activity: Q1 2019 in Review

198 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Heron Therapeutics (HRTX) for Q1 2019, worth a combined $2.27B — down 4.3% from $2.37B a quarter earlier.

Buyers outnumbered sellers: 35 funds opened new HRTX positions and 12 closed out — a net gain of 23 holders — while 77 added to existing stakes and 51 trimmed.

The largest buyer was ClearBridge Investments, adding an estimated $34.6M. The largest seller was Citadel Advisors, cutting an estimated $44.3M.

  • 198 institutional investors held Heron Therapeutics (HRTX) as of Q1 2019, up from 176 in Q4 2018.
  • Funds reported $2.27B of Heron Therapeutics stock for Q1 2019, down 4.3% quarter-over-quarter.
  • 35 funds opened new Heron Therapeutics positions in Q1 2019 and 12 closed out, a net change of +23 holders.
  • The largest Heron Therapeutics buyer in Q1 2019 was ClearBridge Investments, an estimated $34.6M added.
  • The largest Heron Therapeutics seller in Q1 2019 was Citadel Advisors, an estimated $44.3M sold.

Based on aggregated 13F filings for Q1 2019.